FCM Plans for MM-120 (LSD) FDA Approval in 2026 And Extends

FCM Confident in Ability to Start MM-120 Phase III in 2023 and Obtain FDA Approval In 2026 Dr. Freeman and Other FCM Directors Pledge to Extend Lockup...

Related Keywords

New York , United States , Chad , Canada , Canadian , Scott Freeman , Alexander Wodka , Jake Freeman , Riyaz Lalani Dan Gagnier , Farzin Farzaneh , Vivek Jain , Broadridge Investor Communications , Medicine Mindmed Inc , Nasdaq , Exchange Commission The Final , Fcm Mm Holdings , Gagnier Communications , World Trade Center , Globe Newswire Fcm Mm Holdings , Okapi Partners , National Instrument , Running Out , Restore Shareholder Value , Mind Medicine , Restore Value , Public Broadcast , Exchange Commission , Continuous Disclosure Obligations , One World Trade Center , Concerned Shareholders Of Company Mindmed , Znmd , Nasdaq Mnmd , Biotech , Sd ,